Source Capital Healthcare & Disruptive Growth Conference
February 10 & 11, 2016
New York City
Source Capital Group's 2016 Disruptive Growth & Healthcare Conference, February 10-11, 2016, will feature healthcare companies focusing their operations on unmet medical needs, as well as growth companies with disruptive technologies and business models. The panels will cover disruptive innovations and business models, regenerative medicine, immunotherapy, grant writing, and finally a discussion regarding NOLs and rights offerings. The audience is more than 400 institutional investors, accredited investors, family offices, analysts, registered investment advisors, wealth managers, source representatives and their clients – all of whom recognize the tremendous opportunities of disruptive ideas and their infinite potential at market introduction. For more information visit www.SourceGRP.com
Presenting Companies
AdCare Health Systems, Inc. (ADK)
AdCare Health Systems, Inc. (NYSE: ADK), through its subsidiaries, owns, operates and manages skilled nursing facilities and assisted living facilities in the states of Arkansas, Georgia, North Carolina, Ohio, Oklahoma and South Carolina. AdCare's facilities provide a range of health care services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term residents and short-stay patients. As of September 22, 2015, the company owned, leased, or managed for third parties 39 facilities. For more information, visit the company's website at www.adcarehealth.com.
Aemetis, Inc. (AMTX)
Aemetis, Inc. (NASDAQ: AMTX) is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. The company currently owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley, as well as a 50 million gallon per year renewable chemical and advanced fuel production facility on the east coast of India. Aemetis also operates a development laboratory at the Maryland Biotech Center and holds a substantial intellectual property portfolio based on the production of renewable fuels and biochemicals. For more information, visit the company's website at www.aemetis.com.
Applied DNA Sciences, Inc. (APDN)
Applied DNA Sciences, Inc. (NASDAQ: APDN) provides biotechnology-driven solutions to help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Patented botanical DNA solutions can be used to identify, tag, track and trace products to help assure authenticity, traceability and quality of products. SigNature DNA is at the heart of a family of uncopyable, security and authentication solutions such as SigNature T and fiberTyping, for textiles and apparel, DNAnet, for anti-theft and loss prevention, and digitalDNA, providing powerful track and trace. For more information, visit the company's website at www.adnas.com.
Aytu BioScience, Inc. (AYTU)
Aytu BioScience, Inc. (OTC: AYTU) is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on prostate cancer, male sexual dysfunction and male infertility and plans to expand into other urological indications for which there are significant medical needs. The company currently markets ProstaScint® (Capromab Pendetide), the only radioimaging agent indicated to detect prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. For more information, visit the company's website at www.aytubio.com.
NTN Buzztime, Inc. (NTN)
NTN Buzztime, Inc. (NYSE: NTN) delivers interactive entertainment and innovative dining technology to bars and restaurants in North America. Venues license Buzztime's customizable solution to differentiate themselves via competitive fun by offering guests trivia, card, sports and arcade games, nationwide competitions, and self-service dining features including dynamic menus, touchscreen ordering and secure payment. Buzztime's platform improves operating efficiencies, creates connections among the players and venues, and amplifies guests' positive experiences. Founded in 1984, Buzztime has accumulated over 8 million player registrations and over 80 million games were played in 2014 alone. For more information, visit the company's website at www.buzztime.com.
Capstone Turbine Corporation (CPST)
Capstone Turbine Corporation (NASDAQ: CPST) is the world's leading developer and manufacturer of clean-and-green microturbine power generation systems, and was first to market with its high efficiency air bearing turbine technology. Capstone has shipped thousands of microturbines to customers worldwide. These innovative and award-winning systems have logged millions of documented runtime operating hours and are compliant with current and future emissions regulations. For more information, visit the company's website at www.capstoneturbine.com.
Chanticleer Holdings, Inc. (HOTR)
Chanticleer Holdings, Inc. (NASDAQ: HOTR) was formed in 2005 as a business development company and converted to an operating holding company in 2008. In 2011, Chanticleer and a group of noteworthy private equity investors, which included H.I.G. Capital, KarpReilly, LLC and Kelly Hall, president of Texas Wings Inc., the largest Hooters franchisee in the United States, acquired Hooters of America (HOA), a privately held company. Today, HOA is an operator and the franchisor of over 412 Hooters restaurants in 28 countries. For more information, visit the company's website at www.chanticleerholdings.com.
Clean Diesel Technologies, Inc. (CDTI)
Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is a cleantech emissions control company that designs, develops and manufactures sustainable solutions to reduce emissions of on- and off-road engine applications. Within its sector, the company is a global manufacturer and distributor of heavy duty diesel and light duty vehicle emissions control systems and products to major automakers and retrofitters; its business is driven by increasingly stringent global emission standards for internal combustion engines, which are major sources of a variety of harmful pollutants. For more information, visit the company's website at www.cdti.com.
COPsync, Inc. (COYN)
COPsync, Inc. (NASDAQ: COYN) technology improves communication between and among law enforcement officers and agencies from differing jurisdictions to help them prevent and quickly respond to crime. The COPsync Network™ gives officers instant access to actionable, mission-critical data and enables them to share information and communicate in real-time with other officers and agencies, even those hundreds and thousands of miles away. The COPsync911™ threat-alert system enables schools, courts, hospitals and other potentially at-risk facilities to automatically and silently send threat-alerts directly to local law enforcement officers. The company also sells VidTac®, an in-vehicle, software-driven video system for law enforcement. For more information, visit the company's website at www.copsync.com and www.copsync911.com.
Dataram Corp. (DRAM)
Dataram Corp. (NASDAQ: DRAM) is an independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops sold by leading manufacturers such as Dell, Cisco, Fujitsu, HP, IBM, Lenovo and Oracle. Dataram's memory products and solutions are sold worldwide to OEMs, distributors, value-added resellers and end users. Additionally, Dataram manufactures and markets a line of Intel Approved memory products for sale to manufacturers and assemblers of embedded and original equipment. For more information, visit the company's website at www.dataram.com.
Delcath Systems, Inc. (DCTH)
Delcath Systems, Inc. (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology and, more specifically, the treatment of primary and metastatic liver cancers. The company's proprietary product – Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) – is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. For more information, visit the company's website at www.delcath.com.
Digital Ally, Inc. (DGLY)
Digital Ally, Inc. (NASDAQ: DGLY) was created to develop and manufacture technology that provides customers with the ultimate liability protection and evidence recording capabilities, coupled with convenience and ease of use. Established in 2004, Digital Ally adopted a "think tank" approach, utilizing multi-disciplined engineers, sales and support staff, as well as collaborating with cutting-edge firms to design innovative products. Digital Ally's products have been developed for applications in industries such as law enforcement, fire, EMS, and commercial fleet management. For more information, visit the company's website at www.digitalallyinc.com.
Finjan Holdings, Inc. (FNJN)
Finjan Holdings, Inc. (NASDAQ: FNJN) offers investors a diversified and unique vehicle for investing in cybersecurity-related intellectual property-backed technologies under the guidance of a proven team. Finjan's commitment to innovation in the security space continues through its investments which have culminated in the recent launch of Finjan's consulting services business, CybeRisk, development of mobile applications for the consumer and incubation of up-and-coming technology startups pioneering a new generation of security technologies. For more information, visit the company's website at www.finjan.com.
Fusion Telecommunications International, Inc. (FSNN)
Fusion Telecommunications International, Inc. (NASDAQ: FSNN), in concert with its subsidiaries, provides cloud communications, cloud connectivity, cloud computing, and managed cloud-based solutions to small, medium, and large businesses worldwide. The company also offers voice services to communications carriers. Fusion Telecommunications operates in two segments: Business Services and Carrier Services. For more information, visit the company website at www.fusionconnect.com.
Galectin Therapeutics, Inc. (GALT)
Georgia-based Galectin Therapeutics, Inc. (NASDAQ: GALT) is a biotechnology company focused on discovery and development. The company applies its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates are based on its unique carbohydrate technology targeting galectin proteins, which are key mediators of biologic and pathologic function. Galectin is especially pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. For more information, visit the company's website at www.galectintherapeutics.com.
Harris and Harris Group, Inc. (TINY)
Harris and Harris Group, Inc. (NASDAQ: TINY) builds transformative companies from disruptive science. Harris leverages its core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. The company's PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. For more information, visit the company's website at www.hhvc.com.
Inventergy Global, Inc. (INVT)
Inventergy Global, Inc. (NASDAQ: INVT) is the brainchild of one of the intellectual property world's most influential leaders, Joe Beyers. Having led global licensing for Hewlett-Packard for years, Beyers knew first-hand the challenges of leveraging IP assets for technology powerhouses. That's why he joined forces with a handpicked "A-Team" of professionals to assist corporations in getting greater value from your inventions and ideas. The Inventergy team's backgrounds span more than 100 years working for global companies, handling more than $15 billion in IP and technology transactions. For more information, visit the company's website at www.inventergy.com.
Kamada Ltd. (KMDA)
Kamada Ltd. (NASDAQ: KMDA) is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived proteins. For more information, visit the company's website at www.kamada.com.
Lantronix, Inc. (LTRX)
Lantronix, Inc. (NASDAQ: LTRX) is a global networking company that provides M2M (machine to machine) and IoT (Internet of Things) solutions to deliver secure connectivity, device management and mobility. Founded in 1989, Lantronix pioneers robust, intelligent and easy-to-deploy solutions for mission critical applications in a wide range of industries, including data center, medical, security, industrial, transportation, retail, financial and government. Lantronix is headquartered in Irvine, California, with offices in Europe, Asia and Japan. For more information, visit the company's website at www.lantronix.com.
MagneGas Corp. (MNGA)
Tampa-based MagneGas Corp. (NASDAQ: MNGA) is a technology company that counts a patented process that converts liquid waste into hydrogen based fuels among its inventions. The company sells MagneGas into the metal working market as a faster, safer and hotter replacement to acetylene. In addition, the company is developing a variety of ancillary uses for MagneGas fuels by utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information, visit the company's website at www.magnegas.com.
Metabolix, Inc. (MBLX)
Metabolix, Inc. (NASDAQ: MBLX) is an innovation-driven specialty materials company focused on delivering high-performance biopolymer solutions to customers in the plastics industry. Metabolix's Mirel biopolymers, which are derived from renewable resources, are a family of biobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products. For more information, visit the company's website at www.metabolix.com.
NanoViricides, Inc. (NNVC)
NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called "nanoviricides." So far, virus-specific nanoviricide drug candidates against five commercially important viral diseases: viz. seasonal and potentially-epidemic influenzas and bird flu, HIV/AIDS, cold sores and genital herpes infection, viral eye diseases, as well as dengue viruses, have demonstrated very high levels of effectiveness. For more information, visit the company's website at www.nanoviricides.com.
Neurometrix, Inc. (NURO)
Neurometrix, Inc. (NASDAQ: NURO) is an innovative health-care company that develops wearable medical technology and point-of-care test that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company's expertise in biomedical engineering has been refined over nearly two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. NeuroMetrix created the market for point-of-care nerve testing and was first to market with sophisticated, wearable technology for management of chronic pain. For more information, visit the company's website at www.neurometrix.com.
OpGen, Inc. (OPGN)
OpGen, Inc. (NASDAQ: OPGN) is developing and deploying precision medicine tools for antibiotic stewardship management in global healthcare settings, adding real benefits to antimicrobial stewardship programs and assisting clinicians with more rapid information about life threatening infections. Using molecular testing and bioinformatics, OpGen offers a full portfolio of QuickFISH and Acuitas products including the MDRO Gene Test, the Resistome Test, microbial Whole Genome Sequence Analysis, and Acuitas Lighthouse MDRO Management System products. Its QuickFISH products are a suite of FDA-cleared and CE-marked diagnostics for rapid molecular testing of positive blood cultures designed to assure appropriate antibiotic therapy. For more information, visit the company's website at www.opgen.com.
Repro-Med Systems (REPR)
Repro-Med Systems (OTC: REPR), operating as RMS Medical Products, develops and manufactures medical devices and supplies used in emergency care, hospital settings, nursing homes, other medical facilities and home care. The company's principal products are the FREEDOM60® Syringe Infusion System and the RES-Q-VAC® Emergency Medical Suction System. In 2011, the company received FDA approval to market in the U.S. its HIgH-Flo Subcutaneous Needle Sets™. Since 1986, the company has owned and marketed the Gyneco product line, which includes the Masterson Endometrial Biopsy Kit used for in-office biopsy sampling procedures, and the Thermal Cautery System used for tubal ligation procedures. For more information, visit the company's website at www.repro-med.com.
Research Frontiers, Inc. (REFR)
Research Frontiers, Inc. (NASDAQ: REFR) is the developer of SPD-Smart light-control technology, which allows users to instantly, precisely and uniformly control the shading of glass or plastic, either manually or automatically. With the touch of a button, users can instantly change or tune the tint of their glass to help keep out harsh sunlight and 95% of the heat in its tinted (power off) state. Research Frontiers has built an infrastructure of over 40 licensed companies that collectively are capable of serving the growing global demand for smart glass products in automobiles, homes, buildings, museums, aircraft and boats. For more information, visit the company's website at www.smartglass.com.
Rennova Health, Inc. (RNVA)
Rennova Health, Inc. (NASDAQ: RNVA) owns and operates five diagnostics laboratories across the United States that provide clinical testing services specializing in toxicology testing for pain management clinics, drug and alcohol rehabilitation facilities and neurotransmitter testing. Rennova Health offers its customers a complete, turnkey software product including: a proprietary laboratory ordering and reporting application, an advanced laboratory information management system, electronic health records, and an industry-leading platform for interpreting and reporting complex test results to physicians. For more information, visit the company's website at www.rennovahealth.com.
Rosetta Genomics Ltd. (ROSG)
Rosetta Genomics Ltd. (NASDAQ: ROSG) develops and commercializes a broad range of microRNA-based and other high-value molecular diagnostics. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Rosetta is currently working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. For more information, visit the company's website at www.rosettagenomics.com.
Simulations Plus, Inc. (SLP)
Simulations Plus, Inc. (NASDAQ: SLP) is the leading developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide, and food ingredient industries today. The company's software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions... sooner. Founded in 1996, Simulations Plus employs over 30 employees (22 with Ph.D. or M.S. degrees). For more information, visit the company's website at www.simulations-plus.com.
Skyline Medical, Inc. (SKLN)
Skyline Medical, Inc. (NASDAQ: SKLN) produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids. Skyline Medical was founded in 2002 and is based in Eagan, Minnesota. For more information, visit the company's website at www.skylinemedical.com.
U.S. Geothermal, Inc. (HTM)
U.S. Geothermal, Inc. (NYSE: HTM) constructs, manages and operates power plants that utilize geothermal resources in the Western U.S. The company holds interest in the Raft River project comprising two packages of property covering 6,002 acres, including 1,686 acres of federal geothermal rights and 4,316 acres of private leases located in Idaho; the San Emidio project consisting of geothermal power project, 17,846 acres of geothermal leases and ground water rights used for cooling water located in Nevada; and the Neal Hot Springs, geothermal resource located in Eastern Oregon. U.S. Geothermal was incorporated in 2000 and is based in Boise, Idaho. For more information, visit the company's website at www.usgeothermal.com.
VolitionRx (VNRX)
Life sciences company VolitionRx (NYSE: VNRX) is developing diagnostic tests for cancer and other conditions. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. The company's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx's R&D activities are centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S. and ultimately, worldwide. For more information, visit the company's website at www.volitionrx.com.
